August 17, 2026
Here’s how CEO Salim Ramji plans to bring Vanguard’s low-cost, high-return formula to cash savings, financial advice, and active fixed income.
Its stock is down, but investors shouldn’t overreact to worries about the autonomous-vehicle business.
Long Read
Medpace has carved out a niche helping smaller biotechs navigate the regulatory process.
Long Read
Nvidia and other tech stocks have a wide “dispersion” of price targets. Why that could be a problem for investors.
Long Read
Three Pfizer insiders executed transactions directly on the heels of the drugmaker’s second-quarter earnings report.
2 minute read
CFO Charles Chang purchased two Class A shares for $1.5 million. Michael O’Sullivan, the general counsel bought 488 Class B shares for a $250,000.
2 minute read
Some companies deserve the praise and attention that investors are giving them. Ones whose growing margins come from cutting their labor force don’t, Amir Goren writes.
Long Read